Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015, Article ID 543282, 7 pages
http://dx.doi.org/10.1155/2015/543282
Research Article

Serum Enzyme Profiles Differentiate Five Types of Muscular Dystrophy

1Department of Anatomy and Neurobiology, Zhongshan School of Medicine, Sun Yat-sen University, No. 58 Zhongshan 2nd Road, Guangzhou 510080, China
2Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, No. 58 Zhongshan 2nd Road, Guangzhou 510080, China
3Department of Healthcare Clinic, The First Affiliated Hospital, Sun Yat-sen University, No. 58 Zhongshan 2nd Road, Guangzhou 510080, China
4Department of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-sen University, No. 58 Zhongshan 2nd Road, Guangzhou 510080, China
5Department of Epidemiology and Health Statistics, School of Public Health, Sun Yat-sen University, No. 58 Zhongshan 2nd Road, Guangzhou 510080, China

Received 16 February 2015; Revised 9 April 2015; Accepted 15 April 2015

Academic Editor: Donald H. Chace

Copyright © 2015 Yuling Zhu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Mercuri and F. Muntoni, “Muscular dystrophies,” The Lancet, vol. 381, no. 9869, pp. 845–860, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Mohamed, R. Appleton, and P. Nicolaides, “Delayed diagnosis of Duchenne muscular dystrophy,” European Journal of Paediatric Neurology, vol. 4, no. 5, pp. 219–223, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Ciafaloni, D. J. Fox, S. Pandya et al., “Delayed diagnosis in duchenne muscular dystrophy: data from the muscular dystrophy surveillance, tracking, and research network (MD STARnet),” Journal of Pediatrics, vol. 155, no. 3, pp. 380–385, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Begum, M. R. Oliver, A. J. Kornberg, and X. Dennett, “Elevated aminotransferase as a presenting finding in a patient with occult muscle disease,” Journal of Paediatrics and Child Health, vol. 36, no. 2, pp. 189–190, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Bradley, M. M. Aw, and A. Dhawan, “Elevated transaminases: of liver or muscle origin?” Journal of Pediatric Gastroenterology and Nutrition, vol. 34, no. 1, p. 93, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. B. M. Kamath, A. Dhawan, and G. Mieli-Vergani, “Raised serum transaminases: not always liver disease,” Archives of Disease in Childhood, vol. 82, no. 3, pp. 270–271, 2000. View at Google Scholar · View at Scopus
  7. R. Kohli, D. C. Harris, and P. F. Whitington, “Relative elevations of serum alanine and aspartate aminotransferase in muscular dystrophy,” Journal of Pediatric Gastroenterology and Nutrition, vol. 41, no. 1, pp. 121–124, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. D. N. Korones, M. R. Brown, and J. Palis, “'Liver function tests' are not always tests of liver function,” American Journal of Hematology, vol. 66, no. 1, pp. 46–48, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. R. P. Morse and N. P. Rosman, “Diagnosis of occult muscular dystrophy: Importance of the ‘chance’ finding of elevated serum aminotransferase activities,” Journal of Pediatrics, vol. 122, no. 2, pp. 254–256, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. S. K. H. Tay, H. T. Ong, and P. S. Low, “Transaminitis in Duchenne's muscular dystrophy,” Annals of the Academy of Medicine Singapore, vol. 29, no. 6, pp. 719–722, 2000. View at Google Scholar · View at Scopus
  11. N. Urganci, M. Arapoğlu, P. Serdaroğlu, and A. Nuhoğlu, “Incidental raised transaminases: a clue to muscle disease,” Annals of Tropical Paediatrics, vol. 26, no. 4, pp. 345–348, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. A. A. El-Bohy and B. L. Wong, “The diagnosis of muscular dystrophy,” Pediatric Annals, vol. 34, no. 7, pp. 525–530, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Y. Manzur, T. Kuntzer, M. Pike, and A. Swan, “Glucocorticoid corticosteroids for Duchenne muscular dystrophy,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD003725, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. L. P. Rowland, M. Fetell, M. Olarte, A. Hays, N. Singh, and F. E. Wanat, “Emery-Dreifuss muscular dystrophy,” Annals of Neurology, vol. 5, no. 2, pp. 111–117, 1979. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Vajro, E. del Giudice, and C. Veropalumbo, “Muscular dystrophy revealed by incidentally discovered elevated aminotransferase levels,” Journal of Pediatrics, vol. 156, no. 4, p. 689, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Robinson, “Rationale for cost-effective laboratory medicine,” Clinical Microbiology Reviews, vol. 7, no. 2, pp. 185–199, 1994. View at Google Scholar · View at Scopus
  17. D. S. Pratt and M. M. Kaplan, “Evaluation of abnormal liver-enzyme results in asymptomatic patients,” The New England Journal of Medicine, vol. 342, no. 17, pp. 1266–1271, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Wróblewski, “The clinical significance of transaminase activities of serum,” The American Journal of Medicine, vol. 27, no. 6, pp. 911–923, 1959. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Okinaka, H. Sugita, H. Momoi et al., “Serum creatine phosphokinase and aldolase activity in neuromuscular disorders,” Transactions of the American Neurological Association, vol. 84, pp. 62–64, 1959. View at Google Scholar
  20. H. J. McMillan, M. Gregas, B. T. Darras, and P. B. Kang, “Serum transaminase levels in boys with Duchenne and Becker muscular dystrophy,” Pediatrics, vol. 127, no. 1, pp. e132–e136, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Zhang, J.-J. Huang, Z.-Q. Wang, N. Wang, and Z.-Y. Wu, “Value of muscle enzyme measurement in evaluating different neuromuscular diseases,” Clinica Chimica Acta, vol. 413, no. 3-4, pp. 520–524, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. W. G. Yasmineh, G. A. Ibrahim, M. Abbasnezhad, and E. A. Awad, “Isoenzyme distribution of creatine kinase and lactate dehydrogenase in serum and skeletal muscle in Duchenne muscular dystrophy, collagen disease, and other muscular disorders,” Clinical Chemistry, vol. 24, no. 11, pp. 1985–1989, 1978. View at Google Scholar · View at Scopus
  23. M. G. Bialer, D. E. Bruns, and T. E. Kelly, “Muscle enzymes and isoenzymes in Emery-Dreifuss muscular dystrophy,” Clinical Chemistry, vol. 36, no. 3, pp. 427–430, 1990. View at Google Scholar · View at Scopus
  24. R. Tawil, D. A. Figlewicz, R. C. Griggs, and B. Weiffenbach, “Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis,” Annals of Neurology, vol. 43, no. 3, pp. 279–282, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. D. D. Waters, D. O. Nutter, L. C. Hopkins, and E. R. Dorney, “Cardiac features of an unusual X-linked humeroperoneal neuromuscular disease,” The New England Journal of Medicine, vol. 293, no. 20, pp. 1017–1022, 1975. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Beyenburg, S. Zierz, K. Arahata, R. R. Mundegar, W. Friedl, and F. Jerusalem, “Abnormal dystrophin expression in patients with limb girdle syndromes,” Journal of Neurology, vol. 241, no. 4, pp. 210–217, 1994. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Bushby, F. Norwood, and V. Straub, “The limb-girdle muscular dystrophies—diagnostic strategies,” Biochimica et Biophysica Acta, vol. 1772, no. 2, pp. 238–242, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Nalini and N. Gayathri, “Dysferlinopathy: a clinical and histopathological study of 28 patients from India,” Neurology India, vol. 56, no. 3, pp. 379–385, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. J. Jackson, J. M. Round, D. J. Newham, and R. H. T. Edwards, “An examination of some factors influencing creatine kinase in the blood of patients with muscular dystrophy,” Muscle and Nerve, vol. 10, no. 1, pp. 15–21, 1987. View at Publisher · View at Google Scholar · View at Scopus